Market Research Logo

Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023

Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023

“The autoinjectors market is projected to grow at a CAGR of 24.2% during the forecast period.”
The global autoinjectors market is expected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period. Growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing number of regulatory approvals, and technological advancements in autoinjector devices are expected to drive the growth of the autoinjectors market. However, the preference for alternative routes of drug delivery such as oral diabetic agents and epinephrine nasal sprays is expected to restrain the growth of this market to a certain extent.

“By therapy, the rheumatoid arthritis segment is expected to grow at the highest CAGR during the study period.”
Based on therapy, the global autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies. The rheumatoid arthritis segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the high prevalence of rheumatoid arthritis across the globe.

“By type, the disposable autoinjectors segment is expected to grow at the highest rate during the forecast period (2018-2023).”
Based on type, the market is segmented into disposable and reusable autoinjectors. The disposable autoinjectors segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the benefits these autoinjectors offer, such as portability, ease of use, and a lower possibility of infection.

“The North American autoinjectors market is expected to grow at the highest CAGR during the forecast period.”
North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of anaphylaxis, autoimmune diseases, and chronic diseases in the US and Canada; favorable reimbursement scenario; and increasing number of awareness programs in the region.

Break of primary participants was as mentioned below:

The key players in the global autoinjectors market are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), J&J (US), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Bayer (Germany), and Haselmeier (Switzerland).

Research Coverage:
The report analyzes the autoinjectors market and aims at estimating the market size and future growth potential of this market based on various segments such as therapy, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the autoinjectors market. The report analyzes the market based on therapy, type, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the autoinjectors market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various autoinjectors across regions
Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the autoinjectors market
Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market


  • INTRODUCTION
    • OBJECTIVES OF STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • YEARS CONSIDERED FOR THE STUDY
      • MARKETS COVERED
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH METHODOLOGY STEPS
    • SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION METHODOLOGY
    • MARKET DATA VALIDATION AND TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • AUTOINJECTORS MARKET OVERVIEW
    • AUTOINJECTORS MARKET, BY TYPE, 2018 VS. 2023
    • GEOGRAPHIC ANALYSIS: AUTOINJECTORS MARKET, BY THERAPY
    • AUTOINJECTORS MARKET, BY END USER, 2018 VS. 2023
    • GEOGRAPHIC SNAPSHOT: AUTOINJECTORS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table RECENT APPROVALS OF AUTOINJECTOR DEVICES ACROSS THE GLOBE
      • RESTRAINTS
      • OPPORTUNITIES
        • Table PATENT EXPIRY OF KEY BIOLOGICS
      • CHALLENGES
  • AUTOINJECTORS MARKET, BY THERAPY
    • INTRODUCTION
      • Table AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD BILLION)
    • RHEUMATOID ARTHRITIS
      • Table AUTOINJECTORS MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2016-2023 (USD BILLION)
    • MULTIPLE SCLEROSIS
      • Table AUTOINJECTORS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY, 2016-2023 (USD BILLION)
    • DIABETES
      • Table AUTOINJECTORS MARKET FOR DIABETES, BY COUNTRY, 2016-2023 (USD MILLION)
    • ANAPHYLAXIS
      • Table AUTOINJECTORS MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER THERAPIES
      • Table AUTOINJECTORS MARKET FOR OTHER THERAPIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • AUTOINJECTORS MARKET, BY TYPE
    • INTRODUCTION
      • Table COMPARISON OF DISPOSABLE & REUSABLE AUTOINJECTORS
      • Table AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
      • DISPOSABLE AUTOINJECTORS
        • Table DISPOSABLE AUTOINJECTORS MARKET, BY COUNTRY, 2016-2023 (USD BILLION)
      • REUSABLE AUTOINJECTORS
        • Table REUSABLE AUTOINJECTORS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • AUTOINJECTORS MARKET, BY END USER
    • INTRODUCTION
      • Table AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
    • HOME CARE SETTINGS
      • Table AUTOINJECTORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016-2023 (USD BILLION)
    • HOSPITALS & CLINICS
      • Table AUTOINJECTORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • AUTOINJECTORS MARKET, BY REGION
    • INTRODUCTION
      • Table AUTOINJECTORS MARKET, BY REGION, 2016-2023 (USD BILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: AUTOINJECTORS MARKET, BY COUNTRY, 2016-2023 (USD BILLION)
      • Table NORTH AMERICA: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD BILLION)
      • Table NORTH AMERICA: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
      • Table NORTH AMERICA: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
      • US
        • Table AUTOINJECTORS APPROVED BY THE FDA, 2015-2018
        • Table US: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD BILLION)
        • Table US: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
        • Table US: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
      • CANADA
        • Table CANADA: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
        • Table CANADA: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table CANADA: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD MILLION)
    • EUROPE
      • Table PRODUCT APPROVALS IN EUROPE, 2015-2018
      • Table EUROPE: AUTOINJECTORS MARKET, BY COUNTRY, 2016-2023 (USD BILLION)
      • Table EUROPE: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD BILLION)
      • Table EUROPE: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
      • Table EUROPE: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
      • GERMANY
        • Table GERMANY: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
        • Table GERMANY: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
        • Table GERMANY: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
      • UK
        • Table UK: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
        • Table UK: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
        • Table UK: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
      • FRANCE
        • Table FRANCE: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
        • Table FRANCE: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
        • Table FRANCE: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
      • REST OF EUROPE
        • Table ROE: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
        • Table ROE: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table ROE: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: AUTOINJECTORS MARKET, BY COUNTRY, 2016-2023 (USD BILLION)
      • Table ASIA PACIFIC: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD BILLION)
      • Table ASIA PACIFIC: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
      • Table ASIA PACIFIC: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
      • JAPAN
        • Table JAPAN: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
        • Table JAPAN: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
        • Table JAPAN: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
      • CHINA
        • Table CHINA: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
        • Table CHINA: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table CHINA: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • INDIA
        • Table INDIA: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
        • Table INDIA: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table INDIA: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • ROAPAC
        • Table ROAPAC: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
        • Table ROAPAC: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table ROAPAC: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: AUTOINJECTORS MARKET, BY THERAPY, 2016-2023 (USD MILLION)
      • Table ROW: AUTOINJECTORS MARKET, BY TYPE, 2016-2023 (USD BILLION)
      • Table ROW: AUTOINJECTORS MARKET, BY END USER, 2016-2023 (USD BILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • MARKET RANKING OF OEM COMPANIES
    • MARKET SHARE ANALYSIS, BY THERAPEUTIC AREA
      • RHEUMATOID ARTHRITIS
      • MULTIPLE SCLEROSIS
      • DIABETES
      • ANAPHYLAXIS
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES AND APPROVALS
        • Table PRODUCT LAUNCHES AND APPROVALS
      • EXPANSIONS
        • Table EXPANSIONS
      • AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
        • Table AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
  • COMPANY PROFILES
    • ABBVIE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MYLAN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ELI LILLY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • YPSOMED
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • AMGEN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENT
      • MNM VIEW
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • OWEN MUMFORD
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • CONSORT MEDICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • HASELMEIER
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • SHL GROUP (SCANDINAVIAN HEALTH LIMITED)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • JOHNSON & JOHNSON (J&J)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • TEVA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ANTARES PHARMA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report